{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:59:42Z","timestamp":1790787582000,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010270","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T00:00:00Z","timestamp":1380931200000}}],"reference-count":40,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010270.pub2","type":"journal-article","created":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T13:34:28Z","timestamp":1380980068000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Transdermal fentanyl for cancer pain"],"prefix":"10.1002","volume":"2018","author":[{"given":"Gina","family":"Hadley","sequence":"first","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences; Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Pain Research Unit Churchill Hospital Oxford Oxfordshire UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10,5]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD010270.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0885-3924(97)00082-1","article-title":"Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group","volume":"13","author":"Ahmedzai","year":"1997","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD010270.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1090-3801(98)90046-5","article-title":"Transdermal fentanyl for pain control in adults with chronic cancer pain","volume":"2","author":"Kongsgaard","year":"1998","journal-title":"European Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD010270.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jpainsymman.2007.10.023","article-title":"A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain","volume":"36","author":"Kress","year":"2008","journal-title":"Journal of Pain and Symptom Management"},{"issue":"8","key":"10.1002\/14651858.CD010270.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","article-title":"Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management","volume":"12","author":"Mercadante","year":"2008","journal-title":"European Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD010270.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5055\/jom.2005.0044","article-title":"Comparison of transdermal fentanyl with codeine\/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain","volume":"1","author":"Mystakidou","year":"2005","journal-title":"Journal of Opioid Management"},{"issue":"3","key":"10.1002\/14651858.CD010270.pub2-BIB0006|cit6","first-page":"20","article-title":"Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer","volume":"20","author":"Ozt\u00fcrk","year":"2008","journal-title":"Agri"},{"issue":"2","key":"10.1002\/14651858.CD010270.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1185\/030079903125002829","article-title":"Radiotherapy plus either transdermal fentanyl or paracetamol and codeine for painful bone metastases: a randomised study of pain relief and quality of life","volume":"20","author":"Pistevou-Gompaki","year":"2004","journal-title":"Current Medical Research and Opinion"},{"issue":"6","key":"10.1002\/14651858.CD010270.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1185\/030079903125002045","article-title":"Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain","volume":"19","author":"Seventer","year":"2003","journal-title":"Current Medical Research and Opinion"},{"issue":"3","key":"10.1002\/14651858.CD010270.pub2-BIB0009|cit9","first-page":"25","article-title":"Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain","volume":"35","author":"Wong","year":"1997","journal-title":"Acta Anaesthesiologica Sinica"},{"issue":"3","key":"10.1002\/14651858.CD010270.pub2-BIB0010|cit10","first-page":"134","article-title":"Comparison of the analgesic efficacy of intravenous morphine infusion and transdermal fentanyl in oncology patients with mucositis","volume":"4","author":"Ergenoglu","year":"2010","journal-title":"Anatolian Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD010270.pub2-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"Sarhan T Doghem M A comparison of two trans-dermal drug delivery systems; buprenorphine and fentanyl for chronic cancer pain management European Journal of Pain. 6th Congress of the European Federation of IASP Chapters: Pain in Europe 6th, EFIC Lisbon Portugal 2009 S199","DOI":"10.1016\/S1090-3801(09)60693-5"},{"issue":"7","key":"10.1002\/14651858.CD010270.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ejpain.2008.09.005","article-title":"Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine","volume":"13","author":"Wirz","year":"2009","journal-title":"European Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD010270.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/SPC.0b013e3283437a39","article-title":"Transdermal opioids for cancer pain","volume":"5","author":"Cachia","year":"2011","journal-title":"Current Opinion in Supportive and Palliative Care"},{"key":"10.1002\/14651858.CD010270.pub2-BIB0014|cit14","unstructured":"Cancer Research UK Cancer incidence for all cancers combined http:\/\/info.cancerresearchuk.org\/cancerstats\/incidence\/all-cancers-combined\/ [Accessed 22 May 2013]"},{"issue":"9","key":"10.1002\/14651858.CD010270.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1185\/030079904X2114","article-title":"Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain","volume":"20","author":"Clark","year":"2004","journal-title":"Current Medical Research and Opinion"},{"issue":"6","key":"10.1002\/14651858.CD010270.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1089\/jpm.2007.9842","article-title":"The pharmacologic management of cancer pain","volume":"10","author":"Cleary","year":"2007","journal-title":"Journal of Palliative Medicine"},{"issue":"6977","key":"10.1002\/14651858.CD010270.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD010270.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD010270.pub2-BIB0019|cit19","unstructured":"Durogesic\u00ae DTrans http:\/\/www.medicines.org.uk\/EMC\/medicine\/17088\/ (Accessed 22 May 2013)"},{"issue":"2","key":"10.1002\/14651858.CD010270.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/15360280902899921","article-title":"Can observational studies provide a realistic alternative to randomized controlled trials in palliative care?","volume":"23","author":"Hadley","year":"2009","journal-title":"Journal of Pain & Palliative Care Pharmacotherapy"},{"issue":"1-2","key":"10.1002\/14651858.CD010270.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pain.2009.04.012","article-title":"Transdermal fentanyl in cachectic cancer patients","volume":"144","author":"Heiskanen","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD010270.pub2-BIB0022|cit22","article-title":"Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). Available from www.cochrane-handbook.org","author":"Altman","year":"2011"},{"issue":"1","key":"10.1002\/14651858.CD010270.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD010270.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00003495-199753010-00011","article-title":"A review of its pharmacological properties and therapeutic efficacy in pain control","volume":"53","author":"Jeal","year":"1997","journal-title":"Drugs"},{"issue":"13","key":"10.1002\/14651858.CD010270.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2165\/00002018-200326130-00004","article-title":"Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain","volume":"26","author":"Kornick","year":"2003","journal-title":"Drug Safety"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD010270.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"ES39","DOI":"10.36076\/ppj.2012\/15\/ES39","article-title":"A systematic review of randomized trials on the effectiveness of opioids for cancer pain","volume":"15","author":"Koyyalagunta","year":"2012","journal-title":"Pain Physician"},{"issue":"2","key":"10.1002\/14651858.CD010270.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD010270.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/0885-3924(92)90048-M","article-title":"Transdermal fentanyl: clinical pharmacology","volume":"7 3 Suppl","author":"Lehmann","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD010270.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1533-2500.2007.00155.x","article-title":"Improved cancer pain treatment using combined fentanyl-TTS and tramadol","volume":"7","author":"Marinangeli","year":"2007","journal-title":"Pain Pract"},{"key":"10.1002\/14651858.CD010270.pub2-BIB0030|cit30","article-title":"An evidence-based resource for pain relief","volume-title":"An evidence-based resource for pain relief","author":"McQuay","year":"1998"},{"issue":"10","key":"10.1002\/14651858.CD010270.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/bja\/54.10.1117","article-title":"Dural permeability to narcotics: in vitro determination and application to extradural administration","volume":"54","author":"Moore","year":"1982","journal-title":"British Journal of Anaesthetics"},{"issue":"3","key":"10.1002\/14651858.CD010270.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD010270.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD010270.pub2-BIB0034|cit34","first-page":"50","article-title":"Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates","volume-title":"Statistics with Confidence - Confidence Intervals and Statistical Guidelines","author":"Morris","year":"1995"},{"issue":"15","key":"10.1002\/14651858.CD010270.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2165\/00003495-200161150-00014","article-title":"Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control","volume":"61","author":"Muijsers","year":"2001","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD010270.pub2-BIB0036|cit36","article-title":"The Cochrane Collaboration","volume-title":"Review Manager (RevMan). 5.1","author":"The Nordic Cochrane Centre","year":"The Cochrane Collaboration, 2011"},{"issue":"3","key":"10.1002\/14651858.CD010270.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1089\/jpm.2007.0200","article-title":"Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature","volume":"11","author":"Tassinari","year":"2008","journal-title":"Journal of Palliative Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010270.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0269216311404274","article-title":"Transdermal opioids as front line treatment of moderate to severe cancer pain: a systemic review","volume":"25","author":"Tassinari","year":"2011","journal-title":"Palliative Medicine"},{"issue":"7109","key":"10.1002\/14651858.CD010270.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/bmj.315.7109.635","article-title":"Impact of covert duplicate results on meta-analysis: a case study","volume":"315","author":"Tram\u00e8r","year":"1997","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD010270.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003868.pub3","article-title":"Oral morphine for cancer pain","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010270.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T03:02:00Z","timestamp":1656730920000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010270.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,5]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010270.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,5]]}}}